Saturday , January 18 2020
Home / Mises Institute USA / Can We Trust Generic Drugs? The Ranbaxy Whistleblower Narrates the Pharma Scandal of the Century

Can We Trust Generic Drugs? The Ranbaxy Whistleblower Narrates the Pharma Scandal of the Century

Summary:
Generic drugs represent 90% of the pharmaceutical market. Their use has been encouraged through decades of favorable legislation and subsidies, with authorities claiming they are as safe and effective as brand name drugs. Yet generic preparations tainted with impurities are being reported with increasing frequency. What should doctors and the public know about generic drug ...

Topics:
Michel Accad, Anish Koka considers the following as important:

This could be interesting, too:

Tyler Durden writes The Prospects For A Sound-Money Revolt Against The Dollar And Euro

Titus Gebel writes Hong Kong and Santiago: Making Sense of the Two Protests

Don Boudreaux writes Quotation of the Day…

Tim Worstall writes How glorious that Britain’s green economy is shrinking

Generic drugs represent 90% of the pharmaceutical market. Their use has been encouraged through decades of favorable legislation and subsidies, with authorities claiming they are as safe and effective as brand name drugs. Yet generic preparations tainted with impurities are being reported with increasing frequency. What should doctors and the public know about generic drug manufacture? Our guest, Dinesh Thakur, is the chemist who was at the center of the most important scandal to rock the global pharmaceutical industry in decades.

Leave a Reply

Your email address will not be published. Required fields are marked *